Acurx PharmaceuticalsACXP
13F holders, Q2 2025 (June 30)31holders +7
9new positions
2sold out
1famous investor
$0.51avg. 13F price*
At the end of Q2 2025, 31 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings, up 7 from Q1 2025. 9 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($551K), Prospect Financial Services LLC ($152K) and Geode Capital Management, LLC ($75K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $713K |
| Exits | 2 | $1K |
All 13F filers, Q1 2025 → Q2 2025: 1,615,907 shares bought and 2,505,006 shares sold, net −889,099 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Armistice Capital, LLC | 0.02% | New | 1,078,540 | $551K |
| Prospect Financial Services LLC | 0.09% | Reduce -19.0% | 296,776 | $152K |
| Geode Capital Management, LLC | 0.00% | Reduce -14.6% | 146,404 | $75K |
| Vanguard Group Inc. | 0.00% | Reduce -72.5% | 145,537 | $74K |
| Morgan Stanley | 0.00% | No change | 106,201 | $54K |
| Renaissance Technologies | 0.00% | Add +230.0% | 87,781 | $45K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | Add +466.7% | 85,000 | $43K |
| Sabby Management, LLC | 0.34% | Reduce -96.0% | 81,892 | $42K |
| Susquehanna International Group, LLP | 0.00% | New | 69,745 | $36K |
| O'Brien Greene & Co. Inc | 0.01% | New | 60,000 | $31K |
| Virtu Financial LLC | 0.00% | New | 55,126 | $28K |
| Vanguard Capital Wealth Advisors | 0.02% | Reduce -31.9% | 46,000 | $23K |
| ACT Advisors, LLC. | 0.01% | New | 45,952 | $23K |
| State Street Corp. | 0.00% | No change | 43,466 | $22K |
| UBS Group AG | 0.00% | Add +82366.0% | 38,759 | $20K |
| XTX Topco Ltd | 0.00% | New | 37,685 | $19K |
| Lanark Financial, Inc. | 0.00% | No change | 30,000 | $15K |
| Jane Street Group, LLC | 0.00% | New | 28,024 | $14K |
| Northern Trust Corp. | 0.00% | No change | 27,286 | $14K |
| GPS Wealth Strategies Group, LLC | 0.00% | Add +4600.0% | 23,500 | $12K |
| Group One Trading LLC | 0.00% | Add +1068.0% | 13,607 | $7K |
| Wealthcare Advisory Partners LLC | 0.00% | New | 11,538 | $6K |
| Osaic Holdings, Inc. | 0.00% | Add +9.1% | 10,452 | $5K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 16,394 | $5K |
| Quartz Partners, LLC | 0.00% | No change | 10,000 | $5K |
| Simplex Trading, LLC | 0.00% | Add +392.1% | 6,889 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -5.8% | 4,155 | $2K |
| Bank of America Corp. | 0.00% | Add +857.5% | 1,350 | $689 |
| Semmax Financial Advisors Inc. | 0.00% | Reduce -97.3% | 153 | $684 |
| BlackRock, Inc. | 0.00% | Reduce -96.5% | 1,204 | $615 |
| SBI Securities Co., Ltd. | 0.00% | No change | 284 | $145 |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.